President Biden reaffirmed the core goals of the Inflation Reduction Act (IRA) and spotlighted its critical role in lowering health care costs and fostering economic equity. Recent analyses highlight that these actions reflect a commitment to addressing the urgent need for broader coverage and more affordable medications. This call for Congress to bolster Medicare’s drug price negotiation capabilities suggests that the initial steps under the IRA are just the beginning of a more profound, more expansive effort to reduce health care expenses.